• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)

36.01 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 36.01
Bid (Size) 35.30 (1)
Ask (Size) 36.29 (2)
Prev. Close 36.01
Today's Range 36.01 - 36.01
52wk Range 24.05 - 36.89
Shares Outstanding 388,132,400
Dividend Yield 2.44%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Royalty Pharma Declares Third Quarter 2025 Dividend
July 18, 2025
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors
July 17, 2025
From Royalty Pharma plc
Via GlobeNewswire

Performance

YTD
+39.6%
+39.6%
1 Month
+1.7%
+1.7%
3 Month
+13.6%
+13.6%
6 Month
+19.7%
+19.7%
1 Year
+26.4%
+26.4%

More News

Read More
Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025
July 16, 2025
From Royalty Pharma plc
Via GlobeNewswire
A Look Into Royalty Pharma Inc's Price Over Earnings
June 23, 2025
Via Benzinga
How Is The Market Feeling About Royalty Pharma?
June 19, 2025
Via Benzinga
Earnings Scheduled For May 8, 2025
May 08, 2025
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
July 09, 2025
Via Benzinga
2 Surging Stocks to Research Further and 1 to Be Wary Of
June 26, 2025
Via StockStory
Revolution Medicines To Advance Lead Cancer Drug With $2 Billion In Funds
June 24, 2025
Via Benzinga
Revolution Medicines To Get Up To $2B For Development Of Cancer Drug From Royalty Pharma
June 24, 2025
Via Stocktwits
Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion
June 24, 2025
From Royalty Pharma plc
Via GlobeNewswire
Q1 Rundown: Royalty Pharma (NASDAQ:RPRX) Vs Other Branded Pharmaceuticals Stocks
June 18, 2025
Via StockStory
Topics Artificial Intelligence Intellectual Property
RPRX Q1 Earnings Call: Flat Revenue, Portfolio Expansion, and Capital Return Initiatives
June 09, 2025
Via StockStory
2 Value Stocks to Target This Week and 1 to Turn Down
June 06, 2025
Via StockStory
Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
June 04, 2025
From Royalty Pharma plc
Via GlobeNewswire
1 Stock Under $50 with Competitive Advantages and 2 to Question
June 04, 2025
Via StockStory
12 Health Care Stocks Moving In Friday's After-Market Session
May 23, 2025
Via Benzinga
Royalty Pharma Completes the Acquisition of Its External Manager
May 16, 2025
From Royalty Pharma plc
Via GlobeNewswire
3 of Wall Street’s Favorite Stocks with Mounting Challenges
May 15, 2025
Via StockStory
Royalty Pharma to Present at Upcoming Investor Conferences
May 13, 2025
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition
May 12, 2025
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma (NASDAQ:RPRX) Posts Q1 Sales In Line With Estimates
May 08, 2025
Via StockStory
Royalty Pharma Reports First Quarter 2025 Results
May 08, 2025
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of Earnings
May 07, 2025
Via StockStory
Topics Artificial Intelligence
Royalty Pharma PLC - CL A (NASDAQ:RPRX) Shows Strong Technical Setup for Breakout Investors
May 01, 2025
Via Chartmill

Frequently Asked Questions

Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?
Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.
What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?
Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?
The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market
What is the current price of Royalty Pharma plc - Class A Ordinary Shares?
The current price of Royalty Pharma plc - Class A Ordinary Shares is 36.01
When was Royalty Pharma plc - Class A Ordinary Shares last traded?
The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 07/23/25 04:00 PM ET
What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?
The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 13.98B
How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?
Royalty Pharma plc - Class A Ordinary Shares has 14B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap